Cell-cycle inhibition by independent CDK and PCNA binding domains in p21Cip1
The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
Mammalian cell-cycle control by antimitogenic signals involves p21Cip1/WAF1 (refs 1-4), p27Kip1 (refs 5, 6) and p57Kip2 (refs 7, 8), a family of proteins that bind to and inhibit cyclin-dependent kinases (CDKs) required for initiation of S phase. The protein p21 also binds to the DNA polymerase delta processivity factor, proliferating-cell nuclear antigen (PCNA), and inhibits in vitro PCNA-dependent DNA replication. The CDK and PCNA inhibitory activities of p21 are shown here to be functionally independent and to reside in separate protein domains. The PCNA binding and inhibitory activities, which are not observed with p27 or p57, reside in the C-terminal domain of p21, whereas the CDK inhibitory activity resides in the conserved N-terminal domains of these proteins. When separately overexpressed in mammalian cells, the CDK and PCNA inhibitory domains prevent DNA replication, demonstrating a dual function of p21 as a cell-cycle inhibitor in vivo.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“P21 functions primarily by binding to and inhibiting CDKs, and in addition, p21 halts the cell cycle by blocking PCNA, which is required for DNA replication.150, 151”
From Census and evaluation of p53 target genes (2017) · cites this paper as [150]
In the citing paper
“P21 functions primarily by binding to and inhibiting CDKs, and in addition, p21 halts the cell cycle by blocking PCNA, which is required for DNA replication.150, 151”
From Census and evaluation of p53 target genes (2017) · cites this paper as [150]
In the citing paper
“While the p21/PCNA ratio was reported to never exceed a 1:1 ratio in cells [37,38], a ratio of at least 10:1 is required to block DNA repair by nucleotide excision repair (NER) in vitro [38,39,40,41].”
From CDK-Independent and PCNA-Dependent Functions of p21 in DNA Replication (2020) · cites this paper as [38]
In the citing paper
“While the p21/PCNA ratio was reported to never exceed a 1:1 ratio in cells [37,38], a ratio of at least 10:1 is required to block DNA repair by nucleotide excision repair (NER) in vitro [38,39,40,41].”
From CDK-Independent and PCNA-Dependent Functions of p21 in DNA Replication (2020) · cites this paper as [38]
In the citing paper
“When assessing the effect of p21 on PCNA-dependent DNA synthesis in cells, several reports showed a limited or null effect of p21–PCNA interaction on DNA replication [38,45,46,47,48,49,50,51].”
From CDK-Independent and PCNA-Dependent Functions of p21 in DNA Replication (2020) · cites this paper as [38]
Citations
Cites
WAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321
The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.
Wade Harper, J. (1993) · Cell · doi:10.1016/0092-8674(93)90499-g · Cited by 5,651
p21 is a universal inhibitor of cyclin kinases
Xiong, Y., Hannon, G. J., Zhang, H., Casso, D., Kobayashi, R., & Beach, D. (1993) · Nature · doi:10.1038/366701a0 · Cited by 3,368
A short amino acid sequence able to specify nuclear location
Kalderon, D., Roberts, B. L., Richardson, W. D., & Smith, A. E. (1984) · Cell · doi:10.1016/0092-8674(84)90457-4 · Cited by 2,507
Polyak, K., Lee, M.-H., Erdjument-Bromage, H., Koff, A., Roberts, J. M., Tempst, P., & Massagué, J. (1994) · Cell · doi:10.1016/0092-8674(94)90572-x · Cited by 2,118
Self-citationp27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21
Toyoshima, H., & Hunter, T. (1994) · Cell · doi:10.1016/0092-8674(94)90573-8 · Cited by 2,043
The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA
Waga, S., Hannon, G. J., Beach, D., & Stillman, B. (1994) · Nature · doi:10.1038/369574a0 · Cited by 1,655
Matsuoka, S., Edwards, M. C., Bai, C., Parker, S., Zhang, P., Baldini, A., Harper, J. W., & Elledge, S. J. (1995) · Genes & Development · doi:10.1101/gad.9.6.650 · Cited by 952
Matsushime, H., Ewen, M. E., Strom, D. K., Kato, J.-Y., Hanks, S. K., Roussel, M. F., & Sherr, C. J. (1992) · Cell · doi:10.1016/0092-8674(92)90360-o · Cited by 897
Lee, M. H., Reynisdóttir, I., & Massagué, J. (1995) · Genes & Development · doi:10.1101/gad.9.6.639 · Cited by 889
Self-citation
Research works printed but not linked: 1
- Kelman, Z., Naktinis, V. & O'Donnell, M. Meth. Enzym. (in the press).
Cited by
Items 401–500 of 548
GSK-3β Regulates the Expression of P21 to Promote the Progression of Chordoma
Chen, L., Zuo, Y., Pan, R., Ye, Z., Wei, K.-L., Xia, S., Li, W., Tan, J., & Xia, X. (2021) · Cancer Management and Research · doi:10.2147/cmar.s289883 · Cited by 21
Singh, M., Singh, V., Baul, T. S. B., & Koch, B. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120937 · Cited by 14
Yasuda, H., Kato, A., Miyaji, T., Zhou, H., Togawa, A., & Hishida, A. (2004) · Clinical and Experimental Nephrology · doi:10.1007/s10157-003-0263-x · Cited by 14
“The ability of p21 to bind simultaneously to both CDKs and PCNA suggests that it may mediate the coordination between DNA replication and repair and cell-cycle progression.(22) A similar nuclear distribution of p21 and PCNA is known to be dependent on the DNA–repair capacity of the cell after DNA damage.”
BackgroundInfrequent Mutation of Waf1/p21 Gene, a CDK Inhibitor Gene, in Brain Tumors
Tsumanuma, I., Tanaka, R., Abe, S., Kawasaki, T., Washiyama, K., & Kumanishi, T. (1997) · Neurologia medico-chirurgica · doi:10.2176/nmc.37.150 · Cited by 14
Gong, Y., Deng, S., Zhang, M., Wang, G., Minuk, G. Y., & Burczynski, F. J. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600099 · Cited by 17
“…was not observed in PLC/PRF/5 cells, its 1400 1200 1000 800 600 400 200 0 0 1 2 3 4 5 pCEP-WAF1 pCEP DNA concentration (µg) 1400 1200 1000 800 600 400 200 0 0 1 2 3 4 5 pCEP-WAF1 pCEP DNA concentration (µg) 1100 1000 900 800 700 600 500 400 300 2000 3000 4000 5000 6000 7000 8000 Density [3 H ]T…”
BackgroundDanthinne, X., Aoki, K., Kurachi, A. L., Nabel, G. J., & Nabel, E. G. (1998) · Journal of Virology · doi:10.1128/jvi.72.11.9201-9207.1998 · Cited by 14
Zheng, B., Wang, G., Gao, W., Wu, Q., Zhu, W., & Weng, G. (2020) · Acta Pharmaceutica · doi:10.2478/acph-2020-0017 · Cited by 13
“However, cyclin-dependent kinase inhibitors (CDKIs) can especially recognize and bind with the cyclins/CDKs complex, thus inhibiting their activities and regulating the cell cycle progression.”
BackgroundInfluentialFunctional Analysis of CDK Inhibitor p21WAF1
Fotedar, R., Bendjennat, M., & Fotedar, A. (2004) · Humana Press eBooks · doi:10.1385/1-59259-811-0:055 · Cited by 16
Manganese induces p21 expression in PC12 cells at the transcriptional level
Zhao, F., Zhang, J.-B., Cai, T., Liu, X., Liu, M.-C., Ke, T., Chen, J.-Y., & Luo, W. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.04.027 · Cited by 13
A transcription-based mechanism for oncogenic β-catenin-induced lethality in BRCA1/2-deficient cells
Dagg, R. A., Zonderland, G., Lombardi, E. P., Rossetti, G. G., Groelly, F. J., Barroso, S. I., Tacconi, E. M., Wright, B., Lockstone, H. E., Aguilera, A., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25215-0 · Cited by 14
Expression and Prognostic Significance of Cyclin D3 in Ovarian Adenocarcinomas
Levidou, G., Korkolopoulou, P. A., Thymara, I., Vassilopoulos, I., Saetta, A. A., Gakiopoulou, H., Konstantinidou, A. E., Kairi-Vassilatou, E., Pavlakis, K., & Patsouris, E. (2007) · International Journal of Gynecological Pathology · doi:10.1097/pgp.0b013e31804630a7 · Cited by 10
“Phosphorylation of pRb alleviates this inhibitory influence by liberating E2F, thereby allowing the passage through the G1/S boundary (2,6,7).”
BackgroundNam, D., Song, J.-H., Kim, S., Chiang, S. Y., Kim, J. S., Chung, W., Jang, H.-J., Jung, S. H., Na, Y.-S., Kim, S., et al. (2014) · Journal of Medicinal Food · doi:10.1089/jmf.2012.2628 · Cited by 13
“It negatively modulates cell cycle progression by inhibiting the activities of cyclin E/CDK2 and cyclin D/CDK4 complexes and can block DNA replication by binding to proliferating cell nuclear antigen.(15) We found that HC induced the expression of p21 in a concentration-dependent manner in MM cells (Fig.”
BackgroundSrivastava, V. K., & Busbee, D. L. (2002) · Ageing Research Reviews · doi:10.1016/s1568-1637(02)00011-9 · Cited by 12
Morris, M. C., & Divita, G. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1998.2475 · Cited by 12
Jung, S. Y., Kim, C., Kim, W., Lee, S., Lee, J., Shim, B. S., Kim, S., Ahn, K. S., & Ahn, K. S. (2015) · Phytotherapy Research · doi:10.1002/ptr.5347 · Cited by 11
“It negatively modulates cell cycle progression by inhibiting the activities of cyclin E/CDK2 and cyclinD/CDK4 complexes and blocks DNA replication by binding to proliferating cell nuclear antigen (Luo et al., 1995).”
BackgroundKasprzak, A., Adamek, A., Przybyszewska, W., Olejniczak, K., Biczysko, W., Mozer‐Lisewska, I., & Zabel, M. (2010) · Folia Histochemica et Cytobiologica · doi:10.2478/v10042-009-0096-x · Cited by 11
Dagtas, A. S., & Gilbert, K. M. (2009) · Immunology · doi:10.1111/j.1365-2567.2009.03161.x · Cited by 11
Khanna, A. K. (2005) · BMC Immunology · doi:10.1186/1471-2172-6-22 · Cited by 11
“Studies also [19] demonstrated that the PCNA binding and inhibitory activities reside in the C-terminal domain of p21, compared to the location of the CDK inhibitory activity in the conserved N-terminal domain.”
Kim, C., Lee, I. H., Hyun, H. B., Kim, J.-C., Gyawali, R., Lee, S., Lee, J., Kim, S., Shim, B. S., Cho, S. K., et al. (2016) · Integrative Cancer Therapies · doi:10.1177/1534735416649659 · Cited by 12
“It negatively modulates cell cycle progression by inhibiting the activities of cyclin E/ CDK2 and cyclin D/CDK4 complexes and blocks DNA replication by binding to proliferating cell nuclear antigen.(36) We found that SEYG induced the expression of both p53 and p21 in a concentration-dependent manner in prostate tumor…”
BackgroundCharacterization of Telomere-Binding Activity of Replication Factor C Large Subunit p140
Uchiumi, F., Watanabe, M., & Tanuma, S.-I. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0589 · Cited by 11
Korkolopoulou, P. A., Angelopoulou, M. K., Kontopidou, F. N., Patsouris, E., Christodoulou, P. N., Kittas, C. N., Davaris, P. S., & Pangalis, G. A. (2001) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428190109097662 · Cited by 11
Probing Protein-Protein Interactions with Mass Spectrometry
Kriwacki, R. W., & Siuzdak, G. E. (2003) · Humana Press eBooks · doi:10.1385/1-59259-045-4:223 · Cited by 11
Detection of p21WAF1/Cip1 in brain metastases
Ruan, S., Fuller, G. N., Levin, V. A., Bruner, J. M., & Zhang, W. (1998) · Journal of Neuro-Oncology · doi:10.1023/a:1005972808311 · Cited by 11
Shambaugh, G. E., Haines, G. K., Koch, A. E., Lee, E. J. K., Zhou, J., & Pestell, R. G. (2000) · Brain Research · doi:10.1016/s0006-8993(99)02028-4 · Cited by 12
Alternol induces an S‐phase arrest of melanoma B16F0 cells
Liu, L., Zhang, B., Yuan, X., Wang, P., Sun, X., & Zheng, Q. (2013) · Cell Biology International · doi:10.1002/cbin.10226 · Cited by 10
“The negative effect of p21Cip1 on DNA synthesis relies primarily on its ability to inhibit CDK–cyclindependent pathways (Luo et al., 1995; Nakanishi et al., 1995a, b; Ogryzko et al., 1997).”
BackgroundSayeed, S., Cullen, J. P., Coppage, M. L., Sitzmann, J. V., & Redmond, E. M. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)01761-2 · Cited by 11
Protein structure characterization with mass spectrometry
Kriwacki, R. W., Reisdorph, N. A., & Siuzdak, G. E. (2004) · Journal of Spectroscopy · doi:10.1155/2004/407960 · Cited by 10
“5) have been examined using protein mass mapping which exploits the high mass accuracy, resolution, and sensitivity of MALDI-MS [3,4,16–27].”
MethodPost-transcriptional Destabilization of p21 by Protein Kinase C in Fibroblasts
Walker, J. L., Castagnino, P. A., Chung, B. M., Kazanietz, M. G., & Assoian, R. K. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m609622200 · Cited by 10
Induced p21Cip1in premature baboons with CLD: implications for alveolar hypoplasia
O’Reilly, M. A., Watkins, R. H., Staversky, R. J., & Maniscalco, W. M. (2003) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00171.2003 · Cited by 10
Hyman, T., Rothmann, C., Heller, A., Malik, Z., & Salzberg, S. (2001) · Experimental Hematology · doi:10.1016/s0301-472x(01)00616-6 · Cited by 10
Targeting the Cardiomyocyte Cell Cycle for Heart Regeneration
Locatelli, P., Giménez, C. S., Vega, M. U., Crottogini, A., & Belaich, M. N. (2018) · Current Drug Targets · doi:10.2174/1389450119666180801122551 · Cited by 11
The function of the human papillomavirus oncogenes
Pim, D., Thomas, M., & Banks, L. (2001) · Perspectives in medical virology · doi:10.1016/s0168-7069(01)05006-6 · Cited by 9
Arroyo, M. P., & Wang, T. S. ‐. (1998) · Molecular and General Genetics MGG · doi:10.1007/s004380050676 · Cited by 9
“The cyclin-dependent kinase inhibitor p21 physically interacts with PCNA, suggesting that PCNA has a role in control of cell cycle progression (Xiong et al. 1992; Zhang et al. 1993; Flores et al. 1994; Li et al. 1994; Luo et al. 1995; Podust et al. 1995b; Tournier et al. 1996).”
BackgroundStampone, E., Bencivenga, D., Barone, C., Finizio, M. D., Ragione, F. D., & Borriello, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147428 · Cited by 8
“In the p57 C-terminal region, a QT domain is recognizable that is rich in glutamine and threonine residues, similar to that of p27Kip1 and putatively important in protein–protein interaction [12], and a PCNA (Proliferating Cell Nuclear Antigen) binding region, homologous to that of p21Cip1/WAF1, required for preventin…”
BackgroundDadhania, V. P., Bhushan, B., Apte, U. M., & Mehendale, H. M. (2017) · Dose-Response · doi:10.1177/1559325817690287 · Cited by 10
“Protein p21 has been best defined as negative regulator of cell cycle due to its inhibitory action against cyclin/CDK kinase activity.(52) However, consistent to our findings, it has been reported that p21 is upregulated during liver regeneration depending upon the degree of liver injury and the phase of cell cycle pr…”
ResultTian, H., Zhang, Y., Zhang, Q., Li, S., Liu, Y., & Han, X. (2019) · BioScience Trends · doi:10.5582/bst.2019.01006 · Cited by 8
Bozza, W. P., Yang, K., Wang, J., & Zhuang, Z. (2012) · Analytical Biochemistry · doi:10.1016/j.ab.2012.04.018 · Cited by 11
“Overexpression of this peptide in mammalian cells was able to arrest cell division [19; 20].”
BackgroundCell Cycle Checkpoints and Apoptosis: Potential for Improving Radiation Therapy
Muschel, R. J., McKenna, W. G., & Bernhard, E. J. (1997) · Vitamins and hormones · doi:10.1016/s0083-6729(08)60702-5 · Cited by 8
Maxwell, S. A., Acosta, S., Tombusch, K., & Davis, G. E. (1997) · APOPTOSIS · doi:10.1023/a:1026418010549 · Cited by 8
“The p21 protein encoded by the Waf1/Cip1 gene inhibits the activities of G1 cyclin-dependent protein kinases thereby arresting cells in G1.(27,28) The Gadd45 gene is a target of p53(29) and is involved in DNA excision repair processes.”
BackgroundA novel domain of BRCA1 interacts with p53 in breast cancer cells
Buck, M. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.03.061 · Cited by 8
“After DNA damage, increased synthesis and activity of p53 plays a critical role in p21 expression [19–21] and in the induction of cell cycle arrest and apoptosis [21,42,43].”
BackgroundArendt, T. (2008) · Springer eBooks · doi:10.1007/978-0-387-32671-9_8 · Cited by 8
Schizosaccharomyces pombe Replication and Repair Proteins: Proliferating Cell Nuclear Antigen (PCNA)
Arroyo, M. P., & Wang, T. S. ‐. (1999) · Methods · doi:10.1006/meth.1999.0795 · Cited by 11
Constraining the cell cycle: Regulating cell division and differentiation by gene therapy
Stinchcomb, D. T. (1995) · Nature Medicine · doi:10.1038/nm1095-1004 · Cited by 8
Huang, Y., Gao, X., Yang, E., Yue, K., Cao, Y., Zhao, B., Zhang, H., Dai, S., Zhang, L., Luo, P., et al. (2022) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.17244 · Cited by 6
Zhang, Y., Shi, Y., Liu, Y., Dong, H., Liu, M., Li, Y., & Duan, H. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.08.139 · Cited by 7
Wen, X., Ge, X., Zhou, L., Zhang, Y., Guo, X., & Yang, H. (2021) · Frontiers in Veterinary Science · doi:10.3389/fvets.2021.642095 · Cited by 7
“Moreover, p21 can directly bind to the proliferating cell nuclear antigen (PCNA), a DNA polymerase activity factor, to inhibit DNA synthesis, thereby impeding cell progression (32).”
Backgroundp21CDKN1A and DNA Repair Systems: Recent Findings and Future Perspectives
Tillhon, M., Cazzalini, O., Dutto, I., Lucia, A., & Prosperi, E. (2013) · InTech eBooks · doi:10.5772/54173 · Cited by 7
“Cell cycle progression may be also regulated, independently of cyclins and CDKs, thanks to the strong affinity binding to proliferating cell nuclear antigen (PCNA) [14-17], a protein playing a central role in DNA replication and repair, as well as in other processes of DNA metabolism [18,19].”
BackgroundDutta, A. (1998) · Results and problems in cell differentiation · doi:10.1007/978-3-540-69686-5_2 · Cited by 7
Sapheno-Femoral Junction Pathology: Molecular Mechanism of Saphenous Vein Incompetence
Urbanek, T., Skop, B., Ziaja, K., Wilczok, T., Wiaderkiewicz, R., Pałasz, A., Mazurek, U. M., & Wielgus-Serafińska, E. (2004) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/107602960401000403 · Cited by 7
“Similarly, p21 can bind to PCNA and inhibit its function resulting in both G1 and G2 phase arrest (10,11,23,29).”
BackgroundSubbarayan, R., Rallapalli, S., & Kansrajh, C. (2014) · Cited by 7
Xu, W., Wang, X., Wu, X., Yu, S., Xiong, J., Sang, X., Zheng, Y., & Zhang, Z. (2020) · Aging · doi:10.18632/aging.103704 · Cited by 7
“PCNA is not only a vital factor for DNA polymerase, which is necessary for DNA replication and repair [15, 16], but it can also bind to other PCNA-binding proteins, including p33ING1b, p57 and p21, to promote DNA synthesis [17], cell cycle progression [18, 19], and G1 cell cycle arrest [20].”
BackgroundDynamic Interaction between PARP-1, PCNA and p21waf1/cip1
Prosperi, E., & Scovassi, A. I. (2008) · Springer eBooks · doi:10.1007/0-387-36005-0_7 · Cited by 7
Martínez, J., Palomino, J., Cabello, A., Sepúlveda-Sánchez, J. M., de la Cámara, A. G., & Ricoy, J. (2005) · Histopathology · doi:10.1111/j.1365-2559.2005.02074.x · Cited by 10
“These two mechanisms are stoichiometric, depending on the relative proportions of p21 ⁄WAF1 and CDKs and PCNA targets.(11) The fact that p21 ⁄WAF1 was described as a protein inducible by wt p53, but not by mutant p53, led to the idea that the p53 tumour suppressor function of p53 is mediated by p21 ⁄WAF1.”
BackgroundYokoyama, Y., Takahashi, Y., Morishita, S., Hashimoto, M., & Tamaya, T. (1997) · Cancer Letters · doi:10.1016/s0304-3835(97)00193-6 · Cited by 7
Simonsen, S., Larsen, F. B., Søgaard, C. K., Jonsson, N., Lindorff‐Larsen, K., Bruheim, P., Otterlei, M., Hartmann‐Petersen, R., & Kragelund, B. B. (2025) · The FEBS Journal · doi:10.1111/febs.70133 · Cited by 7
“As p21 functions as a master regulator of PCNA and checkpoint activator [35,37,38], neither its localisation, its binding to PCNA, nor its degradation via binding to the CRL4 Cdt2 complex and the E3-ligase can be allowed to be compromised.”
Jung, M.-S., Kim, W., Cho, J. W., Yang, W. H., & Chung, I. K. (2022) · Biochemical Journal · doi:10.1042/bcj20220391 · Cited by 9
Anti-proliferative effect of Annona extracts on breast cancer cells
Veisaga, M., AHUMADA, M., SORIANO, S., ACUNA, L., Zhang, W., Leung, I., Barnum, R., & Barbieri, M. A. (2023) · Biocell · doi:10.32604/biocell.2023.029076 · Cited by 7
Fang, Y., Hu, Y., Wu, P., Wang, B., Tian, Y., Xia, X., Zhang, Q., Chen, T., Jiang, X., Ma, Q., et al. (2011) · Cancer Investigation · doi:10.3109/07357907.2010.496756 · Cited by 6
“It is well known that p21 is a negative regulator of cell cycle progression and a modulator of apoptosis (26, 27).”
BackgroundUkwade, C. E., Ebuehi, O. A. T., Adisa, R. A., Singh, S. K., & Singh, R. (2020) · Journal of Ovarian Research · doi:10.1186/s13048-020-00679-8 · Cited by 8
Huss, R., Theis, S., & Deeg, H. J. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690768 · Cited by 7
“The PCNA binding activity is not observed with p27 or p (Luo et al, 1995). cdkis are considered versatile negative reg tors of cell proliferation, likely in a cell-type specific mann (Elledge et al, 1994).”
BackgroundActivity of DNA polymerase α in aging humanfibroblasts
Srivastava, V. K., Miller, S., Schroeder, M., Crouch, E., & Busbee, D. L. (2000) · Biogerontology · doi:10.1023/a:1010084706732 · Cited by 7
“The initiation of S phase in the mammalian cell cycle involves a family of proteins such as p21 and p27 (Luo et al. 1995) that are inhibitors of cyclin-dependent kinases, which might be one mechanism coupling the initiation of DNA synthesis to cell cycle controls.”
BackgroundInfluentialAntigen p57/Kip2 as a potential negative regulator of human astrocytoma growth
Akaishi, K., Nakayama, J., Sakai, K., Kobayashi, T., & Rutka, J. T. (2009) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2009.05.007 · Cited by 5
Shelly, L. L., Fuchs, C., & Miele, L. (1999) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(19990501)73:2<164::aid-jcb3>3.0.co;2-0 · Cited by 104
Ashcroft, M. A., & Vousden, K. H. (2001) · Humana Press eBooks · doi:10.1007/978-1-59259-230-2_7 · Cited by 5
Promwikorn, W., Hawley, S. R., & Pennington, S. R. (2000) · Cellular Signalling · doi:10.1016/s0898-6568(00)00104-2 · Cited by 4
Functions of p21Waf1 in Norm and in Stress
Timofeev, O. V., Pospelova, T. V., & Поспелов, В. А. (2004) · Molecular Biology · doi:10.1023/b:mbil.0000032199.57820.43 · Cited by 4
“binding site in the C-terminal region [15, 19].”
BackgroundInhibiteurs des kinases dépendantes des cyclines et sénescence réplicative
Gerland, L., Ffrench, M., & Magaud, J. (2001) · Pathologie Biologie · doi:10.1016/s0369-8114(01)00249-8 · Cited by 6
Bouchet, B. P., Fauvet, F., Grelier, G., Galmarini, C. M., & Puisieux, A. (2011) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2011.03.002 · Cited by 5
Diabetic LDL inhibits cell-cycle progression via STAT5B and p21waf
Brizzi, M. F., Dentelli, P., Pavan, M., Rosso, A., Gambino, R., Cesaris, M. G. D., Garbarino, G. M., Camussi, G., Pagano, G., & Pegoraro, L. (2002) · Journal of Clinical Investigation · doi:10.1172/jci200213617 · Cited by 4
Lee, C. R., Masuda, C., Yamamoto, S., Wanibuchi, H., Ikemoto, S., Sugimura, K., Nakatani, T., Wada, S., Kishimoto, T., & Fukushima, S. (1998) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/28.3.227 · Cited by 4
Purification and crystallization of cyclin‐dependent kinase inhibitor p21
Mayrose, D., Ke, H., Xiong, Y., & Nichols, M. A. (1996) · Protein Science · doi:10.1002/pro.5560050920 · Cited by 4
Robles, S. J., Shiyanov, P. A., ARISTODEMO, G. T., Raychaudhuri, P., & Adami, G. R. (1998) · DNA and Cell Biology · doi:10.1089/dna.1998.17.9 · Cited by 4
“The first 80 amino acids of p21 are sufficient for binding P21 is a cell cycle regulatory protein originally shown to cdk2 and for inhibition of S phase entry in many cell lines to be induced by the p53 tumor suppressor in response to (Chen et al., 1996; Fotedar et al, 1996; Luo et al., 1995).”
p57Kip2 Phosphorylation Modulates Its Localization, Stability, and Interactions
Stampone, E., Bencivenga, D., Dassi, L., Sarnelli, S., Campagnolo, L., Lacconi, V., Ragione, F. D., & Borriello, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252011176 · Cited by 3
Yang, H., Xu, W., Li, Y., Lan, P., Zhang, J., Zhang, Y., & Zhang, C. (2014) · Anti-Cancer Drugs · doi:10.1097/cad.0000000000000101 · Cited by 3
Höti, N., Johnson, T. J., Chowdhury, W. H., & Rodríguez, R. (2018) · Cancers · doi:10.3390/cancers10060202 · Cited by 3
“p21 is a member of the cip/kip family of cyclin-dependent kinase inhibitors (CKIs) which bind to and inhibit activity of cyclin/CDK (Cyclin-dependent kinase) complexes [8] and play an important role in G1 cell cycle check point progression [9].”
Chang, C., LIN, C.-S., Chen, M., Liu, Y., Huang, Y., Lin, P., Chen, Y.-F., CHANG, C.-S., & Kan, L. (2006) · Biophysical Reviews and Letters · doi:10.1142/s1793048006000070 · Cited by 3
Parekh, H. K., Pillarisetti, K., Kunapuli, S. P., & Simpkins, H. (1997) · Somatic Cell and Molecular Genetics · doi:10.1007/bf02679973 · Cited by 3
Xie, W., He, Y., Huo, D., Huang, Y., & Wu, W. (2009) · Medical Oncology · doi:10.1007/s12032-009-9386-6 · Cited by 3
“p21 inhibits the cyclin-CDK complex, DNA replication, and the repair factor proliferative cell nuclear antigen (PCNA), which resumes DNA replication upon DNA damage [5].”
BackgroundAbe, H., Saito, F., Tanaka, T., Mizukami, S., Watanabe, Y., Imatanaka, N., Akahori, Y., Yoshida, T., & Shibutani, M. (2016) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2016.08.009 · Cited by 3
Kostopoulou, E., Gil, A. P. R., & Spiliotis, B. E. (2018) · Annals of Pediatric Endocrinology & Metabolism · doi:10.6065/apem.2018.23.4.204 · Cited by 3
Korkolopoulou, P. A., Konstantinidou, A. E., Thomas-Tsagli, E., Christodoulou, P., Kapralos, P., & Davaris, P. (2000) · Applied immunohistochemistry & molecular morphology · doi:10.1097/00129039-200012000-00005 · Cited by 3
Wang, Z. X., Bhargava, A., Sarkar, R., & Germino, F. J. (1996) · Gene · doi:10.1016/0378-1119(96)00218-1 · Cited by 3
Overview of the regulation of S-phase in Xenopus egg extracts
Chevalier, S., Chartrain, I., Philippe, M., & Ford, C. C. (1995) · Biochimie · doi:10.1016/0300-9084(96)88200-9 · Cited by 3
Designing Fluorescent Nuclear Permeable Peptidomimetics to Target Proliferating Cell Nuclear Antigen
Horsfall, A. J., Chav, T., Pederick, J. L., Kikhtyak, Z., Vandborg, B. C., Kowalczyk, W., Scanlon, D. B., Tilley, W. D., Hickey, T. E., Abell, A. D., et al. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c00471 · Cited by 2
Ye, W., Cao, J., Tang, X.-J., Liu, C., Hao, D., Jin, J., & Lü, J. (2016) · International Conference on Biological Sciences and Technology (BST) · doi:10.2991/bst-16.2016.18 · Cited by 3
“Our observation that D-gal-induced S phase arrest in cell cycle and p21 up-regulation (Fig.1 D-F) was in agreement with the previous reports that the cancer cells were treated with the chemicals [14]. p21 is an inhibitor of CDKs and its up-expression usually induces cell cycle arrest at the G1 phase by inhibiting CDKs…”
BackgroundDynamics insights into CDK4/6–CyclinD1 complex stability modulated by abemaciclib
Zhao, Y., Chen, Z., Liu, H., Zeng, C., Gao, J., Wei, Z., & Zhao, Y. (2025) · Physical Chemistry Chemical Physics · doi:10.1039/d5cp00098j · Cited by 1
Cao, Y., Qiao, S., Yuan, Y., Huang, J., & Zhao, S. (1999) · Science in China Series C Life Sciences · doi:10.1007/bf02882057 · Cited by 1
Rb deficiency induces p21cip1 expression and delays retinal degeneration in rd1 mice
Lv, Z., Xiao, L., Tang, Y., Chen, Y., & Chen, D. (2021) · Experimental Eye Research · doi:10.1016/j.exer.2021.108701 · Cited by 3
UV Response of Mammalian p53 Tumor Supressor Gene
Mälkönen, T. (1999) · Helda - University of Helsinki Institutional Repository · Cited by 1
Jordán, R. P. (2011) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-14852 · Cited by 1
Mitsunobu, O. N. O., Shindoh, M., Kobayashi, M., Higashino, F., Kohgo, T., Yoshida, K., & Totsuka, Y. (2004) · Oral Medicine & Pathology · doi:10.3353/omp.9.19 · Cited by 1
“2 (16) and its protein product forms a quaternary complex with cyclin, cyclin-dependent kinase (cdk) and the proliferating cell nuclear antigen (PCNA) (16, 18, 19). p21Waf1/Cip1 was shown to inhibit the kinase activity of cdks and to play a key role in cell-cycle arrest (20, 21).”
BackgroundThe p53 Transcription Factor as Therapeutic Target in Cancer
Asker, C., Bykov, V. J. N., Méndez‐Vidal, C., Selivanova, G., Wilhelm, M., & Wiman, K. G. (2004) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-18932-6_7 · Cited by 1
Vaccinia virus modulates the host cell cycle to promote infection
Martin, C. K. (2019) · UCL Discovery (University College London) · Cited by 1
Schmidt, A.-K. (2021) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-8624 · Cited by 1
The Identification of Cooperating Mutations in TAL1-Mediated Leukemia in the Mouse: A Dissertation
Calvo, J. A. (2005) · The Journal of the American Medical Association (JAMA) Network (American Medical Association) · doi:10.13028/987p-s242 · Cited by 1
Kallassy, M., Martel, N., Damour, O., Yamasaki, H., & Nakazawa, H. (1998) · Molecular Carcinogenesis · doi:10.1002/(sici)1098-2744(199801)21:1<26::aid-mc5>3.3.co;2-p · Cited by 37
P53-Mediated Apoptosis: Regulatory and Mechanistic Aspects
Haupt, Y., Rowan, S., Shaulian, E., Gottlieb, E., Yonish-Rouach, E., Vousden, K. H., & Oren, M. (1996) · Springer eBooks · doi:10.1007/978-1-4615-5895-8_5 · Cited by 1
Cell Cycle Regulation in Intestinal Epithelial Cells
Gartel, A. L., Gartel, M., Goufman, E., & Tyner, A. L. (1996) · Springer eBooks · doi:10.1007/978-3-642-61180-3_7
Ventilation-induced Alterations in Lung Development
Kroon, A. A. (2011) · EUR Research Repository (Erasmus University Rotterdam)
Cycle cellulaire et polarisation du zygote Fucus régulations et interactions
Corellou, F. (2000) · HAL
Metadata
- Authors
- Luo, Y., Hurwitz, J., & Massagué, J.
- Affiliations
- Memorial Sloan Kettering Cancer Center (US)
- ORCID
- Massagué, Joan
- Venue
- Nature
- Published
- 1995-05
- Volume
- 375
- Issue
- 6527
- Pages
- 159-161
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2030231219
- Cited by
- 549
- References
- 18
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 3 · 2023: 3 · 2022: 7 · 2021: 11 · 2020: 11 · 2019: 6 · 2018: 8 · 2017: 13 · 2016: 12 · 2015: 9 · 2014: 8 · 2013: 7 · 2012: 16
- FWCI
- 23.57
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Microtubule and mitosis dynamics
- Keywords
- p21, cyclin-dependent kinases, proliferating cell nuclear antigen, C-terminal domain, cell cycle inhibition, DNA replication inhibition, p27, p57KIP2, S phase entry
- MeSH terms
- Amino Acid Sequence, Animals, Binding Sites, Cell Cycle, DNA, Humans, Molecular Sequence Data, Recombinant Fusion Proteins, Cyclins, Protein Serine-Threonine Kinases, Proliferating Cell Nuclear Antigen, Cyclin-Dependent Kinases, CDC2-CDC28 Kinases, Cyclin-Dependent Kinase Inhibitor p21, Cyclin-Dependent Kinase 2, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.